City

Seoul (1)

Condition

Minimal Residual Disease (1)

Pediatric ALL, B Cell (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Seoul National University Hospital (1)

Collaborator

Amgen (1)

Intervention

blinatumomab for injection (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

pediatric all, b cell

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pediatric ALL, B Cell, Minimal Residual Disease Trial in Seoul (Blinatumomab for Injection)

Recruiting

Pediatric ALL, B Cell
Minimal Residual Disease

Blinatumomab for Injection

Seoul, Korea, Republic of

Seoul National University Hospital

Feb 20, 2022